1. Home
  2. MGRM vs CTOR Comparison

MGRM vs CTOR Comparison

Compare MGRM & CTOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MGRM
  • CTOR
  • Stock Information
  • Founded
  • MGRM 2016
  • CTOR 2021
  • Country
  • MGRM United States
  • CTOR United States
  • Employees
  • MGRM N/A
  • CTOR N/A
  • Industry
  • MGRM Medical/Dental Instruments
  • CTOR
  • Sector
  • MGRM Health Care
  • CTOR
  • Exchange
  • MGRM Nasdaq
  • CTOR NYSE
  • Market Cap
  • MGRM 89.6M
  • CTOR 89.9M
  • IPO Year
  • MGRM N/A
  • CTOR N/A
  • Fundamental
  • Price
  • MGRM $2.79
  • CTOR $1.21
  • Analyst Decision
  • MGRM Strong Buy
  • CTOR Strong Buy
  • Analyst Count
  • MGRM 1
  • CTOR 2
  • Target Price
  • MGRM $4.00
  • CTOR $4.50
  • AVG Volume (30 Days)
  • MGRM 33.0K
  • CTOR 82.4K
  • Earning Date
  • MGRM 03-14-2025
  • CTOR 02-21-2025
  • Dividend Yield
  • MGRM N/A
  • CTOR N/A
  • EPS Growth
  • MGRM N/A
  • CTOR N/A
  • EPS
  • MGRM N/A
  • CTOR N/A
  • Revenue
  • MGRM $364,999.00
  • CTOR N/A
  • Revenue This Year
  • MGRM N/A
  • CTOR N/A
  • Revenue Next Year
  • MGRM N/A
  • CTOR N/A
  • P/E Ratio
  • MGRM N/A
  • CTOR N/A
  • Revenue Growth
  • MGRM N/A
  • CTOR N/A
  • 52 Week Low
  • MGRM $1.53
  • CTOR $0.85
  • 52 Week High
  • MGRM $4.90
  • CTOR $49.00
  • Technical
  • Relative Strength Index (RSI)
  • MGRM 56.61
  • CTOR N/A
  • Support Level
  • MGRM $2.66
  • CTOR N/A
  • Resistance Level
  • MGRM $2.85
  • CTOR N/A
  • Average True Range (ATR)
  • MGRM 0.12
  • CTOR 0.00
  • MACD
  • MGRM -0.01
  • CTOR 0.00
  • Stochastic Oscillator
  • MGRM 61.96
  • CTOR 0.00

About MGRM Monogram Orthopaedics Inc.

Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.

About CTOR CITIUS ONCOLOGY INC

Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.

Share on Social Networks: